Eli Lilly and Co
Change company Symbol lookup
Select an option...
LLY Eli Lilly and Co
$RFTREES Refinitiv Eurozone ESG Select Index
PFC Premier Financial Corp (OHIO)
TWTR Twitter Inc
BCEI Bonanza Creek Energy Inc
RNGR Ranger Energy Services Inc
BAC Bank of America Corp
DIS Walt Disney Co
AAPL Apple Inc
MCD McDonald's Corp
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Price
Delayed
$186.69
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 2,826 shares is on pace to be much lighter than LLY's 10-day average volume of 4,751,353 shares.

2,826

Latest Earnings (Q3 ending 09/2020)

Q3
$1.54
Q3 Consensus estimate
$1.71

Latest Earnings Estimate Range

Highest
estimate
$1.84
Mean
estimate
$1.71
Lowest
estimate
$1.50

Quarterly Consensus Estimates and Ranges

LLY's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.